These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1113389)

  • 1. Chemotherapy of advanced renal cell carcinoma with vinblastine and CCNU.
    Merrin C; Mittelman A; Fanous N; Walsman Z; Murphy GP
    J Urol; 1975 Jan; 113(1):21-3. PubMed ID: 1113389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCNU, vinblastine, and delalutin therapy in renal cell carcinoma.
    Vosika GJ; Ryan MJ; Fortuny IA; Meyer C; Kiang DT; Theologides A; Kennedy BJ
    Med Pediatr Oncol; 1978; 5(1):89-91. PubMed ID: 370538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of renal cell carcinoma. 2. Single-agent therapy with CCNU].
    Satomi Y; Takai S; Nakahashi M
    Nihon Hinyokika Gakkai Zasshi; 1982 Nov; 73(11):1431-5. PubMed ID: 7154472
    [No Abstract]   [Full Text] [Related]  

  • 4. Testing of chemotherapeutic agents in murine renal cell adenocarcinoma.
    Murphy GP; Williams PD
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):265-77. PubMed ID: 4438832
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer.
    Hahn RG; Temkin NR; Savlov ED; Perlia C; Wampler GL; Horton J; Marsh J; Carbone PP
    Cancer Treat Rep; 1978 Jul; 62(7):1093-5. PubMed ID: 356971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy with CCNU (NSC-79037) and 5-(3, 3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196).
    Chang H; Freireich EJ; Khaliq A; Einhorn L; Gottlieb JA
    Cancer Chemother Rep; 1975; 59(4):769-71. PubMed ID: 1100230
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU.
    Omura G; DiSaia P; Blessing J; Boronow R; Hreshchyshyn M; Park R
    Cancer Treat Rep; 1977 Nov; 61(8):1533-5. PubMed ID: 922756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lomustine treatment of metastatic renal cell carcinoma.
    Mittelman A; Albert DJ; Murphy GP
    JAMA; 1973 Jul; 225(1):32-5. PubMed ID: 4740302
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of chemotherapeutic agents in a new murine renal carcinoma model.
    Hrushesky WJ; Murphy GP
    J Natl Cancer Inst; 1974 Apr; 52(4):1117-22. PubMed ID: 4826582
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer.
    Richards F; Pajak TF; Cooper MR; Spurr CL
    Cancer Chemother Rep; 1973; 57(4):419-22. PubMed ID: 4357670
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer.
    Hahn RG; Begg CB; Davis T
    Cancer Treat Rep; 1981; 65(7-8):711-13. PubMed ID: 7018680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential and combination chemotherapy of advanced gastric cancer.
    Moertel CG; Mittelman JA; Bakemeier RF; Engstrom P; Hanley J
    Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of advanced transitional cell carcinoma of the renal pelvis: report of 3 cases treated with vinblastine and chloroethyl-cyclohexyl-nitrosourea.
    von Eyben F; Mattsson W; Glifberg I; Lindholm CE
    J Urol; 1979 Mar; 121(3):367-8. PubMed ID: 430637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
    Perloff M; Muggia FM; Ackerman C
    Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
    Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: CCNU in teatment of recurrent medulloblastoma.
    Ward HW
    Br Med J; 1974 Mar; 1(5908):642. PubMed ID: 4206861
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
    Williams PD; Kantor P; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of vinblastine and bleomycin in metastatic renal cell carcinoma.
    Knost JA; Oldham RK; Hande KR; Rhamy RK; Greco FA
    Cancer Treat Rep; 1981; 65(3-4):349-50. PubMed ID: 6165469
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.